Otter Creek Advisors, LLC Immunic, Inc. Transaction History

Otter Creek Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 09, 2022	BUY	$9.54 - $14.26 $209,879 - $313,720	22,000 Added 18.33%	142,000 $1.61 Million
Q4 2021 Feb 04, 2022	BUY	$7.34 - $10.25 $146,800 - $205,000	20,000 Added 20.0%	120,000 $1.15 Million
Q3 2021 Nov 10, 2021	BUY	$8.05 - $13.29 $402,500 - $664,500	50,000 Added 100.0%	100,000 $885,000
Q2 2021 Aug 11, 2021	BUY	$11.76 - $16.85 $176,400 - $252,750	15,000 Added 42.86%	50,000 $613,000
Q1 2021 May 10, 2021	BUY	$14.21 - $25.3 $497,350 - $885,500	35,000 New	35,000 $558,000

56.2M

100

350K

Ticker IMUX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,565,000
Market Cap $30.6M
Description
Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and oth...

Get notified when there are updates to the investment portfolio of Otter Creek Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Otter Creek Advisors, LLC with notifications on news.